For the third year in a row, Hyman, Phelps & McNamara, P.C. has been ranked as a “Tier 1” law firm in the area of “FDA Law” by the folks over at U.S. News & World Report, who once again teamed up with Best Lawyers …
Menu
Miscellaneous
- A Three-peat: U.S. News & World Report Ranks HP&M as Top Tier FDA Law FirmNovember 15th, 2012
- HP&M’s Dave Clissold to Speak at Management Forum Conference on Orphan Drug, Regulatory Strategy Matters, and MoreNovember 15th, 2012
Hyman, Phelps & McNamara, P.C. is pleased to announce that David B. Clissold will be speaking at an upcoming Management Forum conference on myriad topics, including orphan drug exclusivity, FDA regulatory strategies, and advanced therapy products. The conference, titled “EU and US Regulatory Issues for …
- Hyman, Phelps & McNamara, P.C. Names Two New DirectorsOctober 31st, 2012
Hyman, Phelps & McNamara, P.C. is very pleased to announce that Dara Katcher Levy and Anne K. Walsh have been named Directors of the firm. Ms. Levy devotes a significant portion of her practice to the review of launch and post-launch promotional materials, and also …
- The Obesity Epidemic: FDA’s Growing Waistline!September 3rd, 2012
By Kurt R. Karst – One recent afternoon we returned to our office from a meeting to find the new (2012) nine-volume set of Title 21 of the Code of Federal Regulations (“CFR”) placed on our desk chair. There’s a special place on our desk …
- The Rabbit Hole Runs Deep; CDRH “Whistleblower” Scandal Involves a Once-Secret qui tam LawsuitAugust 26th, 2012
By James R. Phelps – According to recent reports concerning the widely reported “whistleblower” scandal at FDA’s Center for Devices and Radiological Health (“CDRH”), in 2009, the CDRH dissidents involved in the affair, while still employed at FDA, filed a “secret” Federal False Claims Act suit …
- The ABA Blawg 100 – We Need Your Nominations!August 13th, 2012
It’s that time of year again when we at FDA Law Blog turn to our loyal readers and ask for your help. The American Bar Association (“ABA”) announced that it is now accepting nominations for the 2012 Blawg 100 (the top 100 legal blogs – …
- Anne Walsh to Moderate Panel at FDLI Advertising and Promotion ConferenceAugust 8th, 2012
Hyman, Phelps & McNamara, P.C. is pleased to announce that Anne Walsh will moderate a panel on “Trends and Priorities in Enforcement” at this year’s Food and Drug Law Institute’s (“FDLI”) Advertising and Promotion Conference. The conference will be held in Washington, DC on October …
- Viva Brazil! HP&M’s Doug Farquhar to Present at FDLI Conference in São PauloJune 20th, 2012
Hyman, Phelps & McNamara, P.C. Director Douglas B. Farquhar is a key presenter at the Food and Drug Law Institute’s (“FDLI’s”) upcoming conference in São Paulo, Brazil. The conference, which is scheduled for September 10-11, 2012, is titled “U.S. & Brazil: Navigating New Frontiers in …
- HP&M Webinar: Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA’s Nontraditional Investigative ToolsJune 17th, 2012
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 – 2:00 p.m. ET. From …
- Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA’s Nontraditional Investigative Tools – an HP&M WebinarMay 10th, 2012
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 – 2:00 p.m. ET. From …
- FDA Law Blog Turns the Ripe Old Age of 5!March 5th, 2012
There was a recent piece on National Public Radio debating whether the golden age of blogging is over. One commentator suggested that moving forward, only the most successful blogs thus far (i.e., those blogs with a history of good content and that are able to …
- Job Opportunity: HP&M Seeks Attorney with Significant Medical Device ExperienceDecember 7th, 2011
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks a mid-level to senior associate or counsel with substantial experience in medical device law and regulation to assist with a growing practice. Strong writing skills are required. Compensation is …
- FDA Law Blog Honored by LexisNexisDecember 1st, 2011
FDA Law Blog is pleased to announce that we’ve been selected as one of the LexisNexis Top 25 Torts Law Blogs of 2011! Here’s what the folks at LexisNexis had to say: The Top 25 group includes some of the best talent in the blogosphere and …
- ICD2 2012 Conference – Fostering Innovation and Translational Research in Support of Public Health and Economic GrowthNovember 28th, 2011
The International Conference on Drug Development (“ICD2”), formerly known as the International Industrial Pharmacy Conference, continues its annual tradition of offering an informal forum for the exchange of ideas concerning the drug discovery and development process. The 2012 conference, which is presented by The University …
- Job Opportunity: HPM Seeks Junior Attorney with Clinical or Regulatory BackgroundNovember 14th, 2011
Hyman, Phelps & McNamara, PC, the nation’s largest boutique food and drug regulatory law firm, is seeking a recent law school graduate or junior attorney with prior experience in the pharmaceutical or biotech industries in either clinical or regulatory affairs. Excellent academic credentials and strong …